Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2012

5/15/2012 9:28:36 AM

BURLINGTON, Mass., May 15, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced its financial results for the first quarter ended March 31, 2012.

Read at GlobeNewswire

Read Article at

Related Companies

News Categories

• GlobeNewswire

• Coronado Biosciences

• Biotech/Pharma - Earnings